{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T09:06:05Z","timestamp":1788339965680,"version":"build-2803163510"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fitoterapia"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.fitote.2024.106274","type":"journal-article","created":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T17:20:48Z","timestamp":1731432048000},"page":"106274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Synthesis, biological evaluation and mechanism study based on network pharmacology of amino acids esters of 20(S)-protopanaxadiol as novel anticancer agents"],"prefix":"10.1016","volume":"180","author":[{"given":"Hongliu","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Johnstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghai","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fitote.2024.106274_bb0005","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0006-2952(99)00212-9","article-title":"Ginseng pharmacology - multiple constituents and multiple actions","volume":"58","author":"Attele","year":"1999","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.fitote.2024.106274_bb0010","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11947-021-02697-w","article-title":"Recent Progress on processing technologies, chemical components, and bioactivities of Chinese red ginseng, American red ginseng, and Korean red ginseng","volume":"15","author":"Huang","year":"2022","journal-title":"Food Bioprocess Technol."},{"key":"10.1016\/j.fitote.2024.106274_bb0015","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.fitote.2014.11.019","article-title":"A review of biotransformation and pharmacology of ginsenoside compound K","volume":"100","author":"Yang","year":"2015","journal-title":"Fitoterapia"},{"key":"10.1016\/j.fitote.2024.106274_bb0020","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s12272-009-1117-1","article-title":"Anti-androgen-independent prostate cancer effects of ginsenoside metabolites in vitro: mechanism and possible structure-activity relationship investigation","volume":"32","author":"Li","year":"2009","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.fitote.2024.106274_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2018.01538","article-title":"20(S)-Protopanaxadiol inhibits titanium particle-induced inflammatory Osteolysis and RANKL-mediated Osteoclastogenesis via MAPK and NF-\u03baB signaling pathways","volume":"9","author":"Pan","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.fitote.2024.106274_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2017.00506","article-title":"Protopanaxadiol and Protopanaxatriol-type Saponins ameliorate glucose and lipid metabolism in type 2 diabetes mellitus in high-fat diet\/Streptozocin-induced mice","volume":"8","author":"Deng","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.fitote.2024.106274_bb0035","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1055\/s-0029-1185477","article-title":"20S-Protopanaxadiol inhibits P-glycoprotein in multidrug resistant Cancer cells","volume":"75","author":"Zhao","year":"2009","journal-title":"Planta Med."},{"key":"10.1016\/j.fitote.2024.106274_bb0040","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejphar.2011.06.008","article-title":"20(S)-Protopanaxadiol, a metabolite of ginsenosides, induced cell apoptosis through endoplasmic reticulum stress in human hepatocarcinoma HepG2 cells","volume":"668","author":"Zhu","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.fitote.2024.106274_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2019.02.003","article-title":"Ginsenoside 20(S)-protopanaxadiol inhibits triple-negative breast cancer metastasis in vivo by targeting EGFR-mediated MAPK pathway","volume":"142","author":"Peng","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.fitote.2024.106274_bb0050","first-page":"1","article-title":"20(S)-Protopanaxadiol inhibits angiotensin II-induced epithelial-mesenchymal transition by downregulating SIRT1","volume":"10","author":"Wang","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.fitote.2024.106274_bb0055","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1472-6882-13-2","article-title":"Paraptosis and NF-\u03baB activation are associated with protopanaxadiol-induced cancer chemoprevention","volume":"13","author":"Wang","year":"2013","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.fitote.2024.106274_bb0060","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.3109\/10717544.2014.997843","article-title":"A nanoparticulate drug-delivery system for 20(S)-protopanaxadiol: formulation, characterization, increased oral bioavailability and anti-tumor efficacy","volume":"23","author":"Han","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.fitote.2024.106274_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112087","article-title":"Dammarane-type leads panaxadiol and protopanaxadiol for drug discovery: biological activity and structural modification","volume":"189","author":"Wang","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.fitote.2024.106274_bb0070","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/CAD.0b013e32833fde29","article-title":"Synthesis of protopanaxadiol derivatives and evaluation of their anticancer activities","volume":"22","author":"Du","year":"2011","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.fitote.2024.106274_bb0075","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1016\/j.bmc.2013.04.067","article-title":"20(<i>S<\/i>)-Protopanaxadiol (PPD) analogues chemosensitize multidrug-resistant cancer cells to clinical anticancer drugs","volume":"21","author":"Liu","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.fitote.2024.106274_bb0080","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.addr.2012.10.001","article-title":"Amino acids as promoieties in prodrug design and development","volume":"65","author":"Vig","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.fitote.2024.106274_bb0085","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.foodchem.2014.02.102","article-title":"A novel method for predicting antioxidant activity based on amino acid structure","volume":"158","author":"Garrett","year":"2014","journal-title":"Food Chem."},{"key":"10.1016\/j.fitote.2024.106274_bb0090","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/(SICI)1520-6017(200006)89:6<781::AID-JPS10>3.0.CO;2-7","article-title":"Transport of valganciclovir, a ganciclovir prodrug, via peptide transporters PEPT1 and PEPT2","volume":"89","author":"Sugawara","year":"2000","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.fitote.2024.106274_bb0095","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1152\/physrev.00018.2006","article-title":"Amino acid transport across mammalian intestinal and renal epithelia","volume":"88","author":"Broer","year":"2008","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.fitote.2024.106274_bb0100","doi-asserted-by":"crossref","first-page":"9318","DOI":"10.1074\/jbc.M709530200","article-title":"Molecular basis of prodrug activation by human valacyclovirase, an \u03b1-amino acid ester hydrolase","volume":"283","author":"Lai","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.fitote.2024.106274_bb0105","doi-asserted-by":"crossref","unstructured":"H. Sung, J. Ferlay, R.L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal, F. Bray, Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA-Cancer J. Clin. 71 (2021) 209\u2013249. doi:https:\/\/doi.org\/10.3322\/caac.21660.","DOI":"10.3322\/caac.21660"},{"key":"10.1016\/j.fitote.2024.106274_bb0110","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13020-019-0270-9","article-title":"Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine","volume":"14","author":"Luo","year":"2019","journal-title":"Chin. Med."},{"key":"10.1016\/j.fitote.2024.106274_bb0115","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13020-018-0193-x","article-title":"Siegesbeckia pubescens Makino inhibits Pam3CSK4-induced inflammation in RAW 264.7 macrophages through suppressing TLR1\/TLR2-mediated NF-\u03baB activation","volume":"13","author":"Sang","year":"2018","journal-title":"Chin. Med."},{"key":"10.1016\/j.fitote.2024.106274_bb0120","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13020-019-0260-y","article-title":"Anti-inflammatory activities of Sigesbeckia glabrescens Makino: combined in vitro and in silico investigations","volume":"14","author":"Zhong","year":"2019","journal-title":"Chin. Med."},{"key":"10.1016\/j.fitote.2024.106274_bb0125","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3892\/or.2013.2438","article-title":"Ginseng saponin metabolite 20(S)-protopanaxadiol inhibits tumor growth by targeting multiple cancer signaling pathways","volume":"30","author":"Gao","year":"2013","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.fitote.2024.106274_bb0130","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1142\/S0192415X13500778","article-title":"20(S)-Protopanaxadiol triggers mitochondrial-mediated apoptosis in human lung adenocarcinoma A549 cells via inhibiting the PI3K\/Akt signaling pathway","volume":"41","author":"Zhang","year":"2013","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.fitote.2024.106274_bb0135","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1742-7843.2006.pto_415.x","article-title":"Ginsenoside 20(S)-protopanaxadiol inhibits the proliferation and invasion of human fibrosarcoma HT1080 cells","volume":"98","author":"Li","year":"2006","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.fitote.2024.106274_bb0140","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/cddis.2011.28","article-title":"Cell-type-specific regulation of raft-associated Akt signaling","volume":"2","author":"Liu","year":"2011","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.fitote.2024.106274_bb0145","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.2042-7158.2012.01463.x","article-title":"Caspase-mediated pro-apoptotic interaction of panaxadiol and irinotecan in human colorectal cancer cells","volume":"64","author":"Du","year":"2012","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.fitote.2024.106274_bb0150","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1472-6882-13-194","article-title":"Neutral sphingomyelinase 2 modulates cytotoxic effects of protopanaxadiol on different human cancer cells","volume":"13","author":"Park","year":"2013","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.fitote.2024.106274_bb0155","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/molecules21101396","article-title":"20(S)-Protopanaxadiol phospholipid complex: process optimization, characterization, in vitro dissolution and molecular docking studies","volume":"21","author":"Pu","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.fitote.2024.106274_bb0160","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.steroids.2015.12.005","article-title":"Semisynthesis and bioactive evaluation of oxidized products from 20(S)-ginsenoside Rg3, Rh2, protopanaxadiol (PPD) and their 20(R)-epimers as cytotoxic agents","volume":"106","author":"Yang","year":"2016","journal-title":"Steroids"},{"key":"10.1016\/j.fitote.2024.106274_bb0165","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nrd2315","article-title":"Lisdexamfetamine dimesylate","volume":"6","author":"Elia","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.fitote.2024.106274_bb0170","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1124\/jpet.106.102830","article-title":"Transport characteristics of a novel peptide transporter 1 substrate, antihypotensive drug midodrine, and its amino acid derivatives","volume":"318","author":"Tsuda","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.fitote.2024.106274_bb0175","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1007\/s00216-021-03568-1","volume":"413","author":"Li","year":"2021","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.fitote.2024.106274_bb0180","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/bmc.3878","article-title":"Development and validation of an UPLC-Q\/TOF-MS assay for the quantitation of neopanaxadiol in beagle dog plasma: application to a pharmacokinetic study","volume":"31","author":"Geng","year":"2017","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.fitote.2024.106274_bb0185","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2133\/dmpk.DMPK-12-RG-005","article-title":"The role of inter-segmental differences in P-glycoprotein expression and activity along the rat small intestine in causing the double-peak phenomenon of substrate plasma concentration","volume":"28","author":"Wada","year":"2013","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.fitote.2024.106274_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2020.00933","article-title":"Multi-component comparative pharmacokinetics in rats after Oral administration of<i>Fructus aurantii<\/i>extract, Naringin, Neohesperidin, and Naringin-Neohesperidin","volume":"11","author":"Yuan","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.fitote.2024.106274_bb0195","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3892\/or.2022.8443","article-title":"HSP90 inhibitors and cancer: prospects for use in targeted therapies (review)","volume":"49","author":"Li","year":"2023","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.fitote.2024.106274_bb0200","doi-asserted-by":"crossref","first-page":"6016","DOI":"10.1158\/1078-0432.CCR-14-0174","article-title":"Plasma levels of heat shock protein 90 alpha associated with lung Cancer development and treatment responses","volume":"20","author":"Shi","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.fitote.2024.106274_bb0205","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1007\/s12094-022-02883-y","article-title":"IL-6 secretion of CD4<SUP>+<\/SUP> T cells stimulated by LC3-positive extracellular vesicles in human epithelial ovarian cancer","volume":"24","author":"Zhu","year":"2022","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.fitote.2024.106274_bb0210","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ebiom.2017.09.007","article-title":"Plasma heat shock protein 90alpha as a biomarker for the diagnosis of liver Cancer: an official Large-scale, and Multicenter Clinical Trial","volume":"24","author":"Fu","year":"2017","journal-title":"EBioMedicine"},{"issue":"4","key":"10.1016\/j.fitote.2024.106274_bb0215","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2174\/1568009619666191202101330","article-title":"Old and new approaches to target the Hsp90 chaperone","volume":"20","author":"Sanchez","year":"2020","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.fitote.2024.106274_bb0220","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev.cellbio.13.1.513","article-title":"Cellular functions regulated by Src family kinases","volume":"13","author":"Thomas","year":"1997","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.fitote.2024.106274_bb0225","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1021\/jm401427c","article-title":"Targeting receptor tyrosine kinase MET in Cancer: small molecule inhibitors and clinical Progress","volume":"57","author":"Cui","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.fitote.2024.106274_bb0230","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.semcancer.2019.10.002","article-title":"The potential and controversy of targeting STAT family members in cancer","volume":"60","author":"Verhoeven","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.fitote.2024.106274_bb0235","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/1521-1878(200102)23:2<161::AID-BIES1023>3.0.CO;2-0","article-title":"Activation of STAT proteins and growth control","volume":"23","author":"Bromberg","year":"2001","journal-title":"Bioessays"},{"key":"10.1016\/j.fitote.2024.106274_bb0240","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.molmed.2004.04.006","article-title":"Therapeutic and diagnostic implications of Hsp90 activation","volume":"10","author":"Kamal","year":"2004","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.fitote.2024.106274_bb0245","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.phrs.2015.01.003","article-title":"Src protein-tyrosine kinase structure, mechanism, and small molecule inhibitors","volume":"94","author":"Roskoski","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.fitote.2024.106274_bb0250","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrc1275","article-title":"The stats of cancer - new molecular targets come of age","volume":"4","author":"Yu","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.fitote.2024.106274_bb0255","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.semcancer.2021.06.019","article-title":"Attacking the PI3K\/Akt\/mTOR signaling pathway for targeted therapeutic treatment in human cancer","volume":"85","author":"Yu","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.fitote.2024.106274_bb0260","first-page":"17","article-title":"Targeting PI3K\/Akt signal transduction for cancer therapy","volume":"6","author":"He","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.fitote.2024.106274_bb0265","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrc3860","article-title":"PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting","volume":"15","author":"Thorpe","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.fitote.2024.106274_bb0270","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1158\/2159-8290.CD-18-1175","article-title":"Challenges for the clinical development of PI3K inhibitors: strategies to improve their impact in solid tumors","volume":"9","author":"Hanker","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.fitote.2024.106274_bb0275","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature12912","article-title":"Discovery and saturation analysis of cancer genes across 21 tumour types","volume":"505","author":"Lawrence","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.fitote.2024.106274_bb0280","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.semcancer.2020.09.011","article-title":"Targeting hypoxia-inducible factor-1, for cancer treatment: recent advances in developing small-molecule inhibitors from natural compounds","volume":"80","author":"Ma","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.fitote.2024.106274_bb0285","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.molcel.2010.09.022","article-title":"Hypoxia-inducible factors and the response to hypoxic stress","volume":"40","author":"Majmundar","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.fitote.2024.106274_bb0290","doi-asserted-by":"crossref","first-page":"252","DOI":"10.15252\/embj.201695204","article-title":"Hypoxia-inducible factors: coupling glucose metabolism and redox regulation with induction of the breast cancer stem cell phenotype","volume":"36","author":"Semenza","year":"2017","journal-title":"EMBO J."},{"key":"10.1016\/j.fitote.2024.106274_bb0295","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1136\/jcp.2003.012963","article-title":"Expression of vascular endothelial growth factor, hypoxia inducible factor 1\u03b1, and carbonic anhydrase IX in human tumours","volume":"57","author":"Jubb","year":"2004","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.fitote.2024.106274_bb0300","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","article-title":"VEGF in signaling and disease: beyond discovery and development","volume":"176","author":"Apte","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.fitote.2024.106274_bb0305","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jtho.2020.11.022","article-title":"Altered regulation of HIF-1\u03b1 in naive- and drug- resistant EGFR-mutant NSCLC: implications for a vascular endothelial growth factor-dependent phenotype","volume":"16","author":"Nilsson","year":"2021","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.fitote.2024.106274_bb0310","doi-asserted-by":"crossref","first-page":"25903","DOI":"10.1074\/jbc.M603414200","article-title":"Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1\u03b1 signal pathways increases resistance to apoptosis by up-regulating survivin gene expression","volume":"281","author":"Peng","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.fitote.2024.106274_bb0315","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12943-020-1142-8","article-title":"Vascular endothelial growth factor is an autocrine growth factor, signaling through neuropilin-1 in non-small cell lung cancer (vol 14, pg 45, 2015)","volume":"19","author":"Barr","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.fitote.2024.106274_bb0320","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1158\/1078-0432.CCR-13-1916","article-title":"Wistuba, II, VEGF\/VEGFR-2 upregulates EZH2 expression in lung adenocarcinoma cells and EZH2 depletion enhances the response to platinum-based and VEGFR-2-targeted therapy","volume":"20","author":"Riquelme","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.fitote.2024.106274_bb0325","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1158\/0008-5472.CAN-10-2614","article-title":"Wistuba, II, increased VEGFR-2 gene copy is associated with Chemoresistance and shorter survival in patients with non-small-cell lung carcinoma who receive adjuvant chemotherapy","volume":"71","author":"Yang","year":"2011","journal-title":"Cancer Res."}],"container-title":["Fitoterapia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0367326X2400457X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0367326X2400457X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T03:13:12Z","timestamp":1735355592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0367326X2400457X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":65,"alternative-id":["S0367326X2400457X"],"URL":"https:\/\/doi.org\/10.1016\/j.fitote.2024.106274","relation":{},"ISSN":["0367-326X"],"issn-type":[{"value":"0367-326X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis, biological evaluation and mechanism study based on network pharmacology of amino acids esters of 20(S)-protopanaxadiol as novel anticancer agents","name":"articletitle","label":"Article Title"},{"value":"Fitoterapia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fitote.2024.106274","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106274"}}